Announced
Completed
Synopsis
Jubilant Biosys, a contract research organization and drug discovery company, completed the merger with Jubilant Chemsys, an Indian pharmaceutical company. Financial terms were not disclosed. "We are delighted to make this merger happen and focus our investments for growth to expand both the chemistry as well as integrated drug discovery capabilities. It provides clarity to customers and enables us to better deliver on our '4D' promise of accelerating the discovery process through increased digitization of our operations and information flow," Marcel Velterop, Jubilant Biosys President.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.